. . . . . . . . . . . . "p(HGNC:ESR2) -| bp(GOBP:\"G1/S transition of mitotic cell cycle\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "These findings suggest a possible role for ERbeta in breast cancer and imply that ERbeta-specific ligands may reduce proliferation of ER-positive breast cancer cells through actions on the G(1) phase cell-cycle machinery." . . "Selventa" . . . . "2014-07-03T14:32:15.581+02:00"^^ . . .